Does VEDOLIZUMAB Cause Intestinal obstruction? 1,263 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,263 reports of Intestinal obstruction have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 1.7% of all adverse event reports for VEDOLIZUMAB.
1,263
Reports of Intestinal obstruction with VEDOLIZUMAB
1.7%
of all VEDOLIZUMAB reports
37
Deaths
932
Hospitalizations
How Dangerous Is Intestinal obstruction From VEDOLIZUMAB?
Of the 1,263 reports, 37 (2.9%) resulted in death, 932 (73.8%) required hospitalization, and 14 (1.1%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 1,263 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
INFLIXIMAB-DYYB (409)
Which VEDOLIZUMAB Alternatives Have Lower Intestinal obstruction Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB